Lancet (London, England)

publication venue for

Apparently untreatable hypertension. 2007
Refractory autoimmune thrombocytopenia: response to antiplatelet therapy. 2005
Cerebellar ataxia and coeliac disease. 2003
Gynaecology, forced sterilisation, and asylum in the USA. 1998
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. 1993
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. 1981
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials. 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial. 2025
Evolocumab for prevention of coronary artery bypass failure: timing is everything. 2025
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial. 2025
Mobilising national and regional assets and non-state actors for pandemic preparedness.. 405. 2025
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial.. 405. 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.. 405. 2025
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study. 2023
Pulmonary embolism with thrombus-in-transit across a patent foramen ovale.. 402. 2023
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.. 402. 2023
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.. 402. 2023
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial. 2023
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial. 2023
Building on Pasteur's legacy: producing vaccines in Africa.. 400. 2022
How did living in temporary accommodation during the COVID-19 pandemic affect children younger than 5 years' access to health care and health outcomes? A qualitative study of key professionals in a socially and ethnically diverse and deprived area of London.. 400 Suppl 1. 2022
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial.. 400. 2022
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial. 2022
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial.. 400. 2022
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.. 399. 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.. 399. 2022
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.. 398. 2021
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.. 399. 2021
Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial.. 398. 2021
How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.. 398. 2021
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. 2021
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.. 398. 2021
The Great Gatsby and the challenge of unreliable narrators.. 398. 2021
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.. 397. 2021
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.. 397. 2021
Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial.. 397. 2021
From torture to ultraviolence: medical and legal implications.. 397. 2021
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.. 397. 2021
Future scenarios for the COVID-19 pandemic.. 397. 2021
SARS-CoV-2 variants and ending the COVID-19 pandemic.. 397. 2021
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.. 397. 2021
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.. 397. 2021
Anaesthetic depth and complications after major surgery: an international, randomised controlled trial.. 394. 2019
Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.. 394. 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.. 394. 2019
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.. 394. 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.. 394. 2019
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.. 393. 2019
Trickle-down innovation and the longevity of nations.. 393. 2019
Challenges for immigrant health in the USA-the road to crisis.. 393. 2019
Scientific collaboration in Michael Lewis's The Undoing Project.. 393. 2019
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.. 393. 2018
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.. 391. 2018
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 390. 2017
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 390. 2017
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 390. 2017
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 390. 2017
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.. 390. 2017
Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial.. 390. 2017
Educating religious leaders to promote uptake of male circumcision in Tanzania: a cluster randomised trial.. 389. 2017
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.. 389. 2017
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.. 389. 2017
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.. 389. 2016
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.. 388. 2016
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.. 388. 2016
Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.. 387. 2016
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.. 387. 2016
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.. 388. 2016
Delivering safe and effective analgesia for management of renal colic in the emergency department: a double-blind, multigroup, randomised controlled trial.. 387. 2016
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.. 387. 2016
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.. 387. 2016
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.. 386. 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.. 386. 2015
Rectal bleeding and endoscopy need in Sierra Leone: results of a nationwide, community-based survey.. 385 Suppl 2. 2015
Surgical care by non-surgeons in low-income and middle-income countries: a systematic review.. 385 Suppl 2. 2015
The struggle for equity: an examination of surgical services at two NGO hospitals in rural Haiti.. 385 Suppl 2. 2015
Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial.. 385. 2015
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.. 385. 2015
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.. 385. 2014
Thinking globally to transform cardiovascular care.. 384. 2014
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.. 384. 2014
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.. 384. 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.. 383. 2014
Increasing value and reducing waste: addressing inaccessible research.. 383. 2014
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.. 383. 2013
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.. 382. 2013
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial.. 382. 2013
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.. 382. 2013
Oronasopharyngeal suction versus wiping of the mouth and nose at birth: a randomised equivalency trial.. 382. 2013
Non-communicable diseases and injuries in Pakistan: strategic priorities.. 381. 2013
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.. 381. 2012
Untreated surgical conditions in Sierra Leone: a cluster randomised, cross-sectional, countrywide survey.. 380. 2012
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.. 380. 2012
Oral cholera vaccine and integrated cholera control in Haiti.. 379. 2012
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.. 379. 2012
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.. 378. 2011
Accelerating progress on non-communicable diseases.. 382. 2011
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.. 378. 2011
Establishment of a model academic health system in Qatar.. 379. 2011
Antiretroviral prophylaxis: a defining moment in HIV control.. 378. 2011
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.. 378. 2011
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.. 377. 2011
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study.. 377. 2010
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.. 376. 2010
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.. 376. 2010
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.. 375. 2010
Gardasil: from bench, to bedside, to blunder.. 375. 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.. 375. 2010
Climate change: a time of need and opportunity for the health sector.. 374. 2009
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.. 374. 2009
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.. 374. 2009
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.. 374. 2009
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.. 374. 2009
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.. 374. 2009
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.. 374. 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.. 373. 2009
Vulnerability and ethics: considering our Cartesian hangover.. 373. 2009
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.. 373. 2009
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.. 373. 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.. 373. 2009
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.. 373. 2009
Rheumatoid arthritis.. 373. 2009
On the shifting boundaries of medicine.. 373. 2009
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.. 372. 2008
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.. 372. 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.. 371. 2008
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.. 371. 2008
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.. 370. 2007
Clinical update: new treatments for hot flushes.. 369. 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.. 369. 2007
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.. 369. 2007
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.. 369. 2007
Reducing inequalities from injuries in Europe.. 368. 2006
Global guidelines: is gastroenterology leading the way?. 368. 2006
Decision-making about caesarean delivery.. 367. 2006
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.. 365. 2005
Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study.. 365. 2005
Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation.. 365. 2005
Hip replacement, hip seeding, and epidural anaesthesia.. 365. 2005
Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai.. 365. 2005
Avoiding HIV and dying of syphilis.. 364. 2004
Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids.. 364. 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.. 364. 2004
In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.. 364. 2004
Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe.. 363. 2004
Dual HIV-1 infection associated with rapid disease progression.. 363. 2004
Provision of treatment in HIV-1 vaccine trials in developing countries.. 362. 2003
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.. 361. 2003
Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients.. 361. 2003
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.. 361. 2003
Women's health and human rights in HIV prevention research.. 361. 2003
Building a global culture of science.. 360 Suppl. 2002
Comprehension during informed consent in a less-developed country.. 360. 2002
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.. 360. 2002
Virtual colonoscopy.. 360. 2002
Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial.. 359. 2002
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.. 359. 2002
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.. 359. 2002
Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy.. 359. 2002
Use of proteomic patterns in serum to identify ovarian cancer.. 359. 2002
Counting alleles to predict recurrence of early-stage colorectal cancers.. 359. 2002
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.. 357. 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.. 357. 2001
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.. 356. 2000
Minimising discomfort with fine-needle aspiration cytology of the breast.. 356. 2000
Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.. 356. 2000
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.. 356. 2000
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.. 354. 1999
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.. 354. 1999
Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group.. 354. 1999
Early Lung Cancer Action Project: overall design and findings from baseline screening.. 354. 1999
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).. 353. 1999
Trial of oral miltefosine for visceral leishmaniasis.. 352. 1998
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial.. 352. 1998
Ethics of transmission of hepatitis B virus by health-care workers.. 352. 1998
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.. 352. 1998
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I).. 351. 1998
Rapid accurate field diagnosis of Indian visceral leishmaniasis.. 351. 1998
Number-needed-to-treat and placebo-controlled trials.. 351. 1998
Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients.. 349. 1997
Germline BRCA1 185delAG mutations in Jewish women with breast cancer.. 347. 1996
Poetry on rounds: a model for the integration of humanities into residency training.. 347. 1996
Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.. 346. 1995
Thyroid cancer in children.. 346. 1995
Treatment of opportunistic infections in AIDS.. 346. 1995
Role of renin-angiotensin system in blood pressure regulation in pregnancy.. 345. 1995
Renal function during antihypertensive treatment.. 345. 1995
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam.. 344. 1994
Effect of pregnancy on prognosis for young women with breast cancer.. 343. 1994
Rethinking cancer.. 343. 1994
Genetic alterations in bladder cancer.. 342. 1993
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.. 342. 1993
Bladder cancer and coffee drinking: a summary of case-control research.. 341. 1993
Antibodies to the human 60 kDa heat-shock protein in patients with schizophrenia.. 340. 1992
Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte.. 340. 1992
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis.. 338. 1991
Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients.. 337. 1991
Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.. 337. 1991
Systemic glutathione deficiency in symptom-free HIV-seropositive individuals.. 2. 1989
Tin-protoporphyrin and long wave length ultraviolet light in treatment of psoriasis.. 1. 1989
Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones.. 2. 1988
Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation.. 2. 1988
Prognostic assessment of female fecundity.. 2. 1987
Laboratory testing on cerebrospinal fluid. A reappraisal.. 1. 1987
Cigarette smoking and renovascular hypertension.. 2. 1983
Association of mitral-valve prolapse with low body-weight and low blood pressure.. 2. 1982
Rapid growth rate in breast cancer: a confounding variable in adjuvant-chemotherapy trials.. 1. 1982
Impact of delay in diagnosis on clinical stage of testicular cancer.. 2. 1981
Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease.. 1. 1981
Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin.. 2. 1980
Association between pre-transplant natural kill and graft-versus-host disease after stem-cell transplantation.. 2. 1979
Improved survival-rates in presensitised recipients of kidney transplants by immunosuppression with maternal-source gamma-globulin.. 1. 1978
Circulating thymic-hormone activity in congenital immunodeficiency.. 2. 1977
Use of coagulation tests to predict the clinical progress of pre-eclampsia.. 2. 1976
Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure.. 2. 1976
Anorectal disease in patients with non-haematological malignancy.. 1. 1976
Letter: Treatment of primary hypertension.. 2. 1975
Letter: Screening for hypertension.. 1. 1975
Letter: Muscular dystrophies.. 2. 1974
Letter: Lymphocyte response.. 1. 1974
Epidemics of postoperative wound infections associated with hair carriers.. 2. 1973
Intravenous infusion of contaminated dextrose solution: The Deveonport incident.. 2. 1973
Bell's palsy and infectious mononucleosis.. 2. 1973
A young-child nutrition programme in rural Jamaica.. 1. 1973
Association between polyarteritis and Australia antigen.. 2. 1970
Delayed hypersensitivity in hay-fever.. 1. 1970
Serum-growth hormone and glucose intolerance in renal failure.. 2. 1968
Patient involvement in regulation: an unvalued imperative.. 397. 2021
How low can we go in community-acquired pneumonia therapy?. 397. 2021
Mantle cell lymphoma treatment: plus ça change….. 388. 2016
Defining new standards of care for men with prostate cancer.. 387. 2016
Ibrutinib--a new standard treatment for relapsed mantle cell lymphoma?. 387. 2015
Mortality risk with dual antiplatelet therapy? - Authors' reply.. 386. 2015
Precarious innovation of anti-infective coated devices.. 384. 2014
Childhood cancer, endocrine disorders, and cohort studies.. 383. 2014
Management of unruptured brain arteriovenous malformations.. 383. 2014
Angiogenesis in gastric cancer: hitting the target?. 383. 2013
TRILOGY ACS: prasugrel of benefit only after angiography?. 382. 2013
Promotion of improvement as a science.. 381. 2013
Acute lower respiratory infections in developing countries.. 381. 2013
Implantable device regulation in Europe.. 380. 2012
Metal-on-metal failures--in science, regulation, and policy.. 379. 2012
Statins and risk of incident diabetes.. 375. 2010
Five candidates compete for regional director of WHO EURO. Interview by Clare Kapp and Udani Samarasekera.. 374. 2009
CABG versus PCI for multivessel coronary artery disease.. 373. 2009
Targeted drugs for metastatic renal cell carcinoma.. 370. 2007
Acute lung injury and acute respiratory distress syndrome.. 370. 2007
Surrogate endpoints in assessment of new drugs in colorectal cancer.. 356. 2000
Men in India respond to HIV-1 education.. 352. 1998
High-tech and low-tech predictors of stroke risk.. 352. 1998
Pulmonary hypertension in Gaucher's disease.. 352. 1998
COX provides missing link in mechanism of aspirin in colon cancer.. 351. 1998
Issue of lower limit for LDL cholesterol unresolved.. 351. 1998
Effect of HAART on natural history of AIDS-related opportunistic disorders.. 351. 1998
White-coat hypertension.. 348. 1996
Multidrug-resistant tuberculosis and AIDS.. 343. 1994
Harold Varmus, director, National Institutes of Health. Interview by Richard Horton.. 343. 1994
Cellular and humoral immunity in patients with insulin-dependent diabetes.. 342. 1993
RISE-resistant tuberculous meningitis in AIDS patient.. 341. 1993
VID (very important disease) syndrome.. 337. 1991
Recombinant interferon-alpha for treatment of polycythaemia vera.. 2. 1988
Atenolol in irritable bowel syndrome.. 2. 1987
T-cell-receptor beta-chain gene rearrangements.. 2. 1985
Ileal bypass in the treatment of hyperlipoproteinaemia.. 2. 1973
Integrating HIV, hypertension, and diabetes primary care in Africa. 2023
Childhood cancer survivors: healthy behaviours and late mortality. 2023
Waning effectiveness of COVID-19 vaccines. 2022
Direct-acting antiviral treatment for hepatitis C. 2019
CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus. 2018
Immune-checkpoint blockade in cisplatin-ineligible patients with urothelial cancer. 2016
Metastatic breast cancer: focus on endocrine sensitivity. 2016
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. 2016
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. 2016
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. 2016
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. 2016
No more neglect of helminths and HIV. 2016
Augmentation treatment for α1 antitrypsin deficiency. 2015
Twin-to-twin transfusion syndrome: knowing our boundaries. 2014
Anorexia nervosa in adolescents: challenges remain. 2014
Wiping versus suction to clear neonatal airways at birth. 2013
HIV pre-exposure prophylaxis in injecting drug users. 2013
Lifetime risk of COPD: what will the future bring? 2011
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. 2010
Blood-pressure-related disease is a global health priority. 2008
ISAT trial: coiling or clipping for intracranial aneurysms? 2005
Measures and meaning of blood pressure. 2000
Management of Barrett's oesophagus. 1996
Cyclospora: conquest of an emerging pathogen. 1995
Safety of intranasally administered etripamil: RAPID trial update. 2025
Booster vaccines for COVID-19 vaccine breakthrough cases? 2022
Should global financing be the main priority for pandemic preparedness? 2021
Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection. 2021
Education and research are essential for lasting peace in Yemen. 2020
Female global health leadership: data-driven approaches to close the gender gap. 2019
Closing the NIH Fogarty Center threatens US and global health. 2017
Dietary sodium: paradigm shifts from public health to clinical medicine. 2016
Denosumab and fracture risk in women with breast cancer. 2015
Collaborate to cure: a student perspective on global health. 2015
Antenatal corticosteroids for preterm births in resource-limited settings. 2015
The Middle East Cancer Consortium promotes palliative care. 2015
Radiotherapy for extensive stage small-cell lung cancer. 2015
Appeal to global donors to save the Treatment Action Campaign. 2014
Organ transplantation in China--not yet a new era--Authors' reply. 2014
International comparisons of acute myocardial infarction. 2014
A new era for organ transplantation in China. 2014
Reanalysis of "Bedside detection of awareness in the vegetative state: a cohort study". 2013
Sustainability of task-shifting for antiretroviral treatment. 2012
Antiretroviral prophylaxis for HIV prevention reaches a key milestone. 2012
Bedside detection of awareness in the vegetative state. 2012
Medicine and surgery: the yin and yang of health systems. 2012
Dietary salt and cardiovascular disease. 2011
Eltrombopag for chronic immune thrombocytopenia. 2011
Colorectal cancer. 2010
Use of evidence in WHO recommendations. 2007
Estimation of death rates from pandemic influenza. 2007
Multidrug-resistant, dual-tropic HIV-1 and rapid progression. 2005
Diuretics in the LIFE study. 2004
Catastrophic failures of public health. 2004
Investing in children. 2004
The place for politics? 2003
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. 2002
Mammographic screening: no reliable supporting evidence? 2002
Chemotherapy for non-small-cell lung cancer. 2001
Chemotherapy for non-small-cell lung cancer. 2001
Global tobacco control. 2001
Sodium excretion and cardiovascular mortality. 2001
Blood-pressure-lowering treatment. 2001
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. 2001
Gastro-oesophageal reflux disease. 2000
Role of orexins in sleep and arousal mechanisms. 2000
Pathological and therapeutic distinctions in HUS/TTP. 2000
Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. 1999
Mammography in Asian patients with BRCA1 mutations. 1999
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. 1998
Vascular complications associated with use of HIV protease inhibitors. 1998
Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin. 1998
Saddleback fever due to human granulocytic ehrlichiosis. 1998
Calcium antagonists and cardiovascular events in patients with hypertension and diabetes. 1998
Central venous line and neurological deficit. 1997
Treatment of kala-azar with oral fluconazole. 1996
Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. 1996
Endoscopic sphincterotomy with gallbladder left in situ versus open surgery for common bileduct calculi. 1996
False-positive Lyme disease serology in human granulocytic ehrlichiosis. 1996
Complete remission of metastatic colorectal cancer: a pitfall in a multidrug resistance reversal trial. 1994
Sex difference in measles fatality after introduction of new measles vaccine. 1994
Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. 1992
Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis. 1992
Thrombocytopenia in pregnancy. 1991
Fetal neural graft survival. 1990
Cyclophosphamide versus ifosfamide in paediatric oncology. 1990
Glutathione deficiency and HIV. 1990
Significance of residual leukaemia transcripts after bone marrow transplant for CML. 1990
Endoscope exchange in biliary prosthesis procedures. 1988
Endoscopist protection from biopsy valves. 1988
Leuconostoc, an emerging vancomycin-resistant pathogen. 1987
Laboratory testing on cerebrospinal fluid. 1987
Anti-STLV-IIImac reactivity in HIV seropositive individuals in Sweden. 1986
Salivary progesterone profile after in-vitro fertilisation/embryo transfer. 1985
Two sudden deaths during prophylactic antiemetic treatment with high doses of domperidone and methylprednisolone. 1984
Acute gastric dilatation after endoscopic injection sclerotherapy. 1984
Benefits and risks of multiple transfer with in vitro fertilisation. 1984
Isotretinoin in cutaneous T-cell lymphoma. 1983
Mitral valve prolapse and blood pressure. 1983
Alcohol consumption and breast cancer. 1983
Left-ventricular mass in hypertension. 1982
Gastric enzyme analyses and dyspepsia. 1981
Choline deficiency associated with total parenteral nutrition. 1980
Human pancreatic polypeptide in pancreatic juice. 1979
Inappropriate antihypertensive therapy in the elderly. 1977
Non-surgical aspects of ovarian cancer. 1994
HIV-negative AIDS. 1992
New strategy for allotransplantation.. 348. 1996
MRI for breast cancer screening, diagnosis, and treatment. 2011
Prolonged grief disorder. 2025
Current concepts in coronary artery revascularisation. 2023
The Lancet Commission on lessons for the future from the COVID-19 pandemic. 2022
Improvement in trauma care for road traffic injuries: an assessment of the effect on mortality in low-income and middle-income countries. 2022
Long-term care for people treated for cancer during childhood and adolescence. 2022
Prostate cancer. 2021
Histiocytosis. 2021
Public policy and health in the Trump era. 2021
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. 2020
Inappropriate opioid prescription after surgery. 2019
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. 2018
Autism spectrum disorder. 2018
The Lancet Commission on pollution and health. 2017
A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. 2016
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. 2015
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. 2015
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. 2015
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. 2015
The role of the microbiome in exacerbations of chronic lung diseases. 2014
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. 2014
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. 2013
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. 2011
The future of chronic obstructive pulmonary disease treatment--difficulties of and barriers to drug development. 2011
HIV prevention transformed: the new prevention research agenda. 2011
Treatment of acute postoperative pain. 2011
Biological, clinical, and ethical advances of placebo effects. 2010
Achieving the health Millennium Development Goals for South Africa: challenges and priorities. 2009
Imaging strategies for low-back pain: systematic review and meta-analysis. 2009
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. 2005
Advances in leishmaniasis. 2005
The camptothecins. 2003
Hot flushes. 2002
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. 2002
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. 2000
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. 1998
Neocytolysis: physiological down-regulator of red-cell mass. 1997
Chemotherapy. 1997
Molecular genetics of acute leukaemia. 1997
Adult leukaemia in 1995: new directions. 1995
Hypercoagulable states: molecular genetics to clinical practice. 1994
Non-pharmacological treatment of hypertension. 1994

VIVO Weill Cornell Medical College

Lancet (London, England) Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)